breast cancer and glp 1 drugs cancer: GLP-1 use may substantially lower risk GLP-1 Drugs May Improve Survival
Description
Inflammation in atherosclerosis: pathophysiology and mechanisms
GLP-1 agonists also reduced headache risk, with the most significant effect at 3 months (RR: 0.69), remaining statistically significant at 6, 12, and 24 months
As a secondary end-point, a direct comparison with liraglutide (up to 1.8 mg) was made
Liraglutide improves the kidney function in a murine model of chronic kidney disease
Derek Thompson: So today you are the largest pharmaceutical company in the world, in significant part because of your GLP-1 drug
However, it should be noted that this combination therapy strategy does not reverse the tumor-promoting effects of previous insulin treatments [42]
